Surgery Partners, Inc. (SGRY)
USD 23.08
(2.9%)
USD 23.08
(2.9%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.74 Billion USD | 8.03% |
| 2022 | 2.53 Billion USD | 14.12% |
| 2021 | 2.22 Billion USD | 19.62% |
| 2020 | 1.86 Billion USD | 1.57% |
| 2019 | 1.83 Billion USD | 3.38% |
| 2018 | 1.77 Billion USD | 32.08% |
| 2017 | 1.34 Billion USD | 17.09% |
| 2016 | 1.14 Billion USD | 19.33% |
| 2015 | 959.89 Million USD | 138.02% |
| 2014 | 403.28 Million USD | 41.7% |
| 2013 | 284.59 Million USD | 9.37% |
| 2012 | 260.21 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 762.1 Million USD | 6.23% |
| 2024 Q1 | 717.4 Million USD | -2.45% |
| 2023 Q2 | 667.6 Million USD | 0.21% |
| 2023 Q1 | 666.2 Million USD | -5.78% |
| 2023 FY | 2.74 Billion USD | 8.03% |
| 2023 Q4 | 735.4 Million USD | 9.09% |
| 2023 Q3 | 674.1 Million USD | 0.97% |
| 2022 Q3 | 620.6 Million USD | 0.84% |
| 2022 Q2 | 615.4 Million USD | 3.22% |
| 2022 Q4 | 707.1 Million USD | 13.94% |
| 2022 FY | 2.53 Billion USD | 14.12% |
| 2022 Q1 | 596.2 Million USD | -2.29% |
| 2021 FY | 2.22 Billion USD | 19.62% |
| 2021 Q1 | 512.4 Million USD | -6.55% |
| 2021 Q3 | 559.2 Million USD | 2.93% |
| 2021 Q4 | 610.2 Million USD | 9.12% |
| 2021 Q2 | 543.3 Million USD | 6.03% |
| 2020 Q3 | 496.1 Million USD | 32.4% |
| 2020 FY | 1.86 Billion USD | 1.57% |
| 2020 Q1 | 441 Million USD | -14.73% |
| 2020 Q4 | 548.3 Million USD | 10.52% |
| 2020 Q2 | 374.7 Million USD | -15.03% |
| 2019 Q1 | 416.8 Million USD | -15.14% |
| 2019 Q4 | 517.2 Million USD | 14.42% |
| 2019 Q3 | 452 Million USD | 1.48% |
| 2019 Q2 | 445.4 Million USD | 6.86% |
| 2019 FY | 1.83 Billion USD | 3.38% |
| 2018 Q4 | 491.16 Million USD | 10.64% |
| 2018 Q1 | 417.36 Million USD | -9.34% |
| 2018 Q2 | 444.77 Million USD | 6.57% |
| 2018 Q3 | 443.93 Million USD | -0.19% |
| 2018 FY | 1.77 Billion USD | 32.08% |
| 2017 Q3 | 282.68 Million USD | -1.97% |
| 2017 FY | 1.34 Billion USD | 17.09% |
| 2017 Q4 | 460.34 Million USD | 62.85% |
| 2017 Q2 | 288.35 Million USD | 0.76% |
| 2017 Q1 | 286.18 Million USD | -6.48% |
| 2016 FY | 1.14 Billion USD | 19.33% |
| 2016 Q3 | 282.68 Million USD | -2.42% |
| 2016 Q4 | 306 Million USD | 8.25% |
| 2016 Q2 | 289.68 Million USD | 8.46% |
| 2016 Q1 | 267.07 Million USD | 1.42% |
| 2015 Q2 | 232.82 Million USD | 3.87% |
| 2015 Q1 | 224.14 Million USD | 24.74% |
| 2015 FY | 959.89 Million USD | 138.02% |
| 2015 Q3 | 239.59 Million USD | 2.91% |
| 2015 Q4 | 263.32 Million USD | 9.9% |
| 2014 Q3 | 76.3 Million USD | 1.59% |
| 2014 Q1 | 69.15 Million USD | 0.0% |
| 2014 Q2 | 75.1 Million USD | 8.6% |
| 2014 FY | 403.28 Million USD | 41.7% |
| 2014 Q4 | 179.69 Million USD | 135.5% |
| 2013 FY | 284.59 Million USD | 9.37% |
| 2012 FY | 260.21 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 6.332% |
| Addus HomeCare Corporation | 1.05 Billion USD | -159.132% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -1300.236% |
| Amedisys, Inc. | 2.23 Billion USD | -22.667% |
| Astrana Health, Inc. | 1.38 Billion USD | -97.835% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | -44.749% |
| IMAC Holdings, Inc. | 5.19 Million USD | -52686.223% |
| biote Corp. | 185.36 Million USD | -1379.985% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -8652.318% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | -35.825% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -339.428% |
| The Ensign Group, Inc. | 3.72 Billion USD | 26.44% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | -64.133% |
| InnovAge Holding Corp. | 763.85 Million USD | -259.139% |
| The Joint Corp. | 117.69 Million USD | -2230.828% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | -159.865% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -26383.521% |
| ModivCare Inc. | 2.75 Billion USD | 0.286% |
| NewGenIvf Group Limited | 5.13 Million USD | -53311.571% |
| Option Care Health, Inc. | 4.3 Billion USD | 36.237% |
| P3 Health Partners Inc. | 1.26 Billion USD | -116.626% |
| P3 Health Partners Inc. | 1.26 Billion USD | -116.626% |
| The Pennant Group, Inc. | 544.89 Million USD | -403.458% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -49641.222% |
| Talkspace, Inc. | 150.04 Million USD | -1728.318% |
| Talkspace, Inc. | 150.04 Million USD | -1728.318% |
| The Oncology Institute, Inc. | 324.23 Million USD | -746.073% |
| The Oncology Institute, Inc. | 324.23 Million USD | -746.073% |